The company has successfully deleveraged its balance sheet, reducing total debt from $1.2 billion in 2024Q3 to $1.0 billion by 2026Q4, though goodwill remains a significant asset concentration at $581.1 million.
| Metric | Mar'26 | Mar'25 | Mar'24 | Mar'23 | Mar'22 | Mar'21 | Mar'20 | Mar'19 | Mar'18 | Mar'17 | Mar'16 | Mar'15 | Mar'14 | Mar'13 | Mar'12 | Mar'11 | Mar'10 | Mar'09 | Mar'08 | Mar'07 | Mar'06 | Mar'05 | Mar'04 | Mar'03 | Mar'02 | Mar'01 |
|---|
| Total Current Assets | 431.48M | 448.33M | 375.04M | 391.74M | 293.27M | 269.83M | 365.65M | 300.94M | 303.48M | 334.43M | 249.01M | 201.71M | 177.19M | 164.17M | 147.03M | 107.58M | 112.15M | 103.56M | 85.38M | 83.77M | 86.01M | 79.66M | 30.75M | 3.53M | 7.88M | 0 |
| Cash & Short-Term Investments | 63.87M | 97.88M | 46.47M | 58.49M | 27.18M | 32.3M | 94.76M | 27.53M | 32.55M | 41.85M | 27.23M | 21.32M | 28.33M | 15.67M | 19.02M | 13.33M | 41.1M | 35.18M | 6.08M | 13.76M | 8.2M | 5.33M | 3.39M | 3.53M | 7.88M | 0 |
| Cash Only | 63.87M | 97.88M | 46.47M | 58.49M | 27.18M | 32.3M | 94.76M | 27.53M | 32.55M | 41.85M | 27.23M | 21.32M | 28.33M | 15.67M | 19.02M | 13.33M | 41.1M | 35.18M | 6.08M | 13.76M | 8.2M | 5.33M | 3.39M | 3.53M | 7.88M | 0 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 191.92M | 194.29M | 176.78M | 167.02M | 139.33M | 114.67M | 150.52M | 148.79M | 140.88M | 136.74M | 95.25M | 87.86M | 65.05M | 73.05M | 60.23M | 44.39M | 30.62M | 36.02M | 44.22M | 35.17M | 40.04M | 35.92M | 15.73M | 0 | 0 | 0 |
| Days Sales Outstanding | 64.34 | 62.33 | 57.34 | 54.06 | 46.79 | 44.37 | 57.05 | 55.66 | 49.39 | 56.58 | 43.12 | 44.87 | 39.45 | 42.76 | 49.84 | 48.15 | 37.01 | 42.05 | 49.42 | 40.28 | 49.26 | 43.22 | 65.31 | - | - | - |
| Inventory | 159.13M | 147.71M | 138.72M | 162.12M | 120.34M | 114.96M | 116.03M | 119.88M | 118.55M | 115.61M | 91.26M | 74M | 65.59M | 60.2M | 51.11M | 39.75M | 29.16M | 26.98M | 29.7M | 30.17M | 33.84M | 21.58M | 9.75M | 0 | 0 | 0 |
| Days Inventory Outstanding | 112.99 | 107.12 | 101.08 | 117.78 | 94.23 | 105.99 | 103.09 | 104.13 | 93.12 | 110.53 | 98.25 | 87.58 | 91.43 | 79.5 | 87.3 | 87.6 | 73.62 | 65.89 | 68.56 | 71.91 | 88.59 | 55.73 | 98.08 | - | - | - |
| Other Current Assets | 16.56M | 8.44M | 13.08M | 4.12M | 0 | 0 | 0 | 4.74M | 0 | 40.23M | 10.11M | 8.1M | 6.54M | 6.35M | 5.28M | 10.1M | 11.27M | 5.38M | 3.07M | 2.73M | 3.93M | 8.85M | 1.65M | 0 | 0 | 0 |
| Total Non-Current Assets | 3.12B | 2.95B | 2.94B | 2.96B | 3.38B | 3.16B | 3.15B | 3.14B | 3.46B | 3.58B | 2.7B | 2.47B | 1.62B | 1.58B | 1.61B | 949.34M | 679.26M | 697.82M | 963.78M | 979.65M | 952.63M | 921.48M | 295.87M | 0 | 0 | 0 |
| Property, Plant & Equipment | 171.25M | 127.84M | 89.33M | 89.53M | 98.53M | 102.77M | 90.72M | 51.18M | 52.55M | 50.59M | 15.54M | 13.74M | 9.6M | 9.9M | 1.3M | 1.44M | 1.4M | 1.37M | 1.43M | 1.45M | 1.65M | 2.32M | 880K | 0 | 0 | 0 |
| Fixed Asset Turnover | 6.36x | 8.90x | 12.60x | 12.60x | 11.03x | 9.18x | 10.62x | 19.07x | 19.81x | 17.43x | 51.88x | 52.00x | 62.72x | 63.02x | 338.26x | 233.04x | 216.35x | 228.76x | 227.92x | 219.90x | 179.47x | 130.52x | 99.91x | - | - | - |
| Goodwill | 581.11M | 527.42M | 527.73M | 527.55M | 578.98M | 578.08M | 575.18M | 578.58M | 620.1M | 615.25M | 360.19M | 290.65M | 190.91M | 167.55M | 173.7M | 154.9M | 111.49M | 114.24M | 308.92M | 310.95M | 297.94M | 0 | 55.59M | 0 | 0 | 0 |
| Intangible Assets | 2.3B | 2.3B | 2.32B | 2.34B | 2.7B | 2.48B | 2.48B | 2.51B | 2.78B | 2.9B | 2.32B | 2.13B | 1.39B | 1.37B | 1.4B | 786.36M | 559.23M | 577.59M | 646.68M | 657.16M | 637.2M | 294.54M | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -399.57M | -26K | -715.09M | -10.11M | -8.1M | -6.54M | -6.35M | -5.28M | -5.29M | -6.35M | -4.02M | -3.07M | -2.73M | -3.23M | -5.7M | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 2.17M | 3.27M | 5.72M | 3M | 3.27M | 2.86M | 2.96M | 3.13M | 3.57M | 7.45M | 1.32M | 28.6M | 23.15M | 24.94M | 35.71M | 6.63M | 7.15M | 4.62M | 6.75M | 10.1M | 15.85M | 624.61M | 239.39M | 0 | 0 | 0 |
| Total Assets | 3.55B | 3.4B | 3.32B | 3.35B | 3.67B | 3.43B | 3.51B | 3.44B | 3.76B | 3.91B | 2.95B | 2.67B | 1.8B | 1.74B | 1.76B | 1.06B | 791.41M | 801.38M | 1.05B | 1.06B | 1.04B | 1B | 326.62M | 142.06M | 174.04M | 151.29M |
| Asset Turnover | 0.31x | 0.33x | 0.34x | 0.34x | 0.30x | 0.28x | 0.27x | 0.28x | 0.28x | 0.23x | 0.27x | 0.27x | 0.34x | 0.36x | 0.25x | 0.32x | 0.38x | 0.39x | 0.31x | 0.30x | 0.29x | 0.30x | 0.27x | 0.50x | 0.27x | 0.06x |
| Asset Growth % | 4.27% | 2.53% | -1.05% | -8.63% | 7.04% | -2.41% | 2.12% | -8.5% | -3.85% | 32.64% | 10.47% | 48.66% | 3.21% | -1.05% | 66.36% | 33.55% | -1.24% | -23.62% | -1.34% | 2.38% | 3.75% | 206.51% | 129.92% | -18.38% | 15.04% | - |
| Total Current Liabilities | 120.92M | 106.62M | 117.05M | 160.72M | 143.42M | 122.14M | 149.88M | 126.98M | 123.2M | 162.01M | 106.68M | 99.04M | 84.36M | 96.67M | 63.92M | 54.21M | 55.65M | 34.23M | 37.89M | 40.91M | 35.73M | 38.91M | 14.54M | 0 | 0 | 0 |
| Accounts Payable | 22.79M | 18.93M | 38.98M | 62.74M | 55.76M | 45.98M | 62.38M | 56.56M | 61.39M | 70.22M | 38.3M | 46.12M | 48.29M | 51.38M | 26.73M | 21.61M | 12.77M | 18.05M | 20.54M | 19.3M | 18.07M | 21.7M | 5.28M | 0 | 0 | 0 |
| Days Payables Outstanding | 16.18 | 13.72 | 28.4 | 45.58 | 43.66 | 42.39 | 55.42 | 49.13 | 48.22 | 67.13 | 41.23 | 54.58 | 67.31 | 67.85 | 45.65 | 47.63 | 32.24 | 44.08 | 47.42 | 46.01 | 47.29 | 56.05 | 53.13 | - | - | - |
| Short-Term Debt | 12.55M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29.59M | 3.55M | 3.55M | 3.55M | 3.73M | 3.73M | 2M | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 492K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.14M | -3.73M | -2M | 0 | 0 | 0 |
| Other Current Liabilities | 72.72M | 14.21M | 57.13M | 14.29M | 19.59M | 14.07M | 13.39M | 88K | 1.9M | 22.84M | 11.31M | 4.33M | 3.11M | 35.95M | 29.44M | 25M | 8.06M | 11.2M | 0 | 0 | 11.08M | 9.4M | 0 | 0 | 0 | 0 |
| Current Ratio | 3.57x | 4.20x | 3.20x | 2.44x | 2.04x | 2.21x | 2.44x | 2.37x | 2.46x | 2.06x | 2.33x | 2.04x | 2.10x | 1.70x | 2.30x | 1.98x | 2.02x | 3.03x | 2.25x | 2.05x | 2.41x | 2.05x | 2.11x | - | - | - |
| Quick Ratio | 2.25x | 2.82x | 2.02x | 1.43x | 1.21x | 1.27x | 1.67x | 1.43x | 1.50x | 1.35x | 1.48x | 1.29x | 1.32x | 1.08x | 1.50x | 1.25x | 1.49x | 2.24x | 1.47x | 1.31x | 1.46x | 1.49x | 1.44x | - | - | - |
| Cash Conversion Cycle | 161.15 | 155.73 | 130.01 | 126.25 | 97.36 | 107.97 | 104.72 | 110.66 | 94.28 | 99.98 | 100.14 | 77.88 | 63.57 | 54.41 | 91.49 | 88.12 | 78.38 | 63.85 | 70.56 | 66.19 | 90.56 | 42.9 | 110.26 | - | - | - |
| Total Non-Current Liabilities | 1.54B | 1.46B | 1.55B | 1.75B | 1.95B | 1.95B | 2.19B | 2.22B | 2.46B | 2.93B | 2.1B | 1.94B | 1.15B | 1.17B | 1.29B | 640.88M | 406.7M | 472.77M | 532.19M | 577.17M | 593.5M | 576.38M | 185.57M | 0 | 0 | 0 |
| Long-Term Debt | 993.95M | 992.36M | 1.13B | 1.35B | 1.48B | 1.48B | 1.73B | 1.8B | 1.99B | 2.19B | 1.63B | 1.59B | 934.41M | 970.9M | 1.12B | 486.94M | 294.56M | 374.79M | 407.68M | 459.8M | 494.9M | 491.63M | 146.69M | 0 | 0 | 0 |
| Capital Lease Obligations | 38.92M | 43.36M | 7.7M | 11.54M | 20.59M | 26.52M | 29.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 500.67M | 419.59M | 403.6M | 380.43M | 444.92M | 434.05M | 407.81M | 399.57M | 442.52M | 715.09M | 469.62M | 351.57M | 213.2M | 194.29M | 167.72M | 153.93M | 112.14M | 97.98M | 122.14M | 114.57M | 98.6M | 84.75M | 38.87M | 0 | 0 | 0 |
| Other Non-Current Liabilities | 5.58M | 5.39M | 9.19M | 8.16M | 7.48M | 8.61M | 25.44M | 20.05M | 23.33M | 17.97M | 2.84M | 2.46M | 327K | 0 | 0 | 0 | 0 | 0 | 2.38M | 2.8M | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 1.66B | 1.57B | 1.66B | 1.91B | 2.09B | 2.07B | 2.34B | 2.35B | 2.58B | 3.09B | 2.2B | 2.04B | 1.23B | 1.26B | 1.36B | 695.09M | 462.35M | 507M | 570.08M | 618.08M | 629.24M | 615.29M | 200.11M | 98.2M | 115.3M | 105.26M |
| Total Debt | 1.05B | 1.04B | 1.14B | 1.37B | 1.51B | 1.51B | 1.77B | 1.8B | 1.99B | 2.19B | 1.63B | 1.59B | 934.41M | 970.9M | 1.12B | 486.94M | 324.14M | 378.34M | 411.23M | 463.35M | 498.63M | 495.36M | 148.69M | 0 | 0 | 0 |
| Net Debt | 981.56M | 946.37M | 1.09B | 1.31B | 1.48B | 1.48B | 1.67B | 1.77B | 1.96B | 2.15B | 1.6B | 1.57B | 906.08M | 955.23M | 1.1B | 473.61M | 283.05M | 343.16M | 405.15M | 449.59M | 490.43M | 490.03M | 145.3M | -3.53M | -7.88M | 0 |
| Debt / Equity | 0.55x | 0.57x | 0.69x | 0.94x | 0.95x | 1.12x | 1.51x | 1.64x | 1.69x | 2.67x | 2.18x | 2.53x | 1.66x | 2.03x | 2.79x | 1.35x | 0.99x | 1.29x | 0.86x | 1.04x | 1.22x | 1.28x | 1.18x | - | - | - |
| Debt / EBITDA | 3.07x | 2.85x | 3.05x | 133.90x | 4.16x | 4.62x | 5.37x | 18.12x | 7.99x | 9.48x | 5.72x | 7.05x | 4.62x | 4.73x | 9.90x | 5.65x | 3.52x | - | 3.90x | 4.28x | 5.12x | 4.66x | 6.69x | - | - | - |
| Net Debt / EBITDA | 2.88x | 2.58x | 2.93x | 128.17x | 4.09x | 4.53x | 5.08x | 17.84x | 7.86x | 9.30x | 5.63x | 6.96x | 4.48x | 4.66x | 9.73x | 5.49x | 3.07x | - | 3.84x | 4.15x | 5.04x | 4.61x | 6.54x | -0.11x | -0.42x | - |
| Interest Coverage | 7.31x | 6.97x | 5.11x | -0.36x | 5.08x | 3.48x | 2.98x | 0.64x | 3.03x | 2.18x | 2.84x | 2.57x | 2.48x | 2.26x | 2.48x | 2.78x | 3.30x | -5.92x | - | - | - | - | - | - | - | - |
| Total Equity | 1.89B | 1.83B | 1.66B | 1.45B | 1.58B | 1.36B | 1.17B | 1.1B | 1.18B | 822.55M | 744.34M | 627.62M | 563.36M | 477.94M | 402.73M | 361.83M | 329.06M | 294.38M | 479.07M | 445.33M | 409.41M | 385.85M | 126.51M | 43.86M | 58.74M | 46.03M |
| Equity Growth % | 2.87% | 10.86% | 14.37% | -8.27% | 16.15% | 16% | 6.86% | -7.02% | 43.29% | 10.51% | 18.6% | 11.41% | 17.87% | 18.68% | 11.3% | 9.96% | 11.78% | -38.55% | 7.58% | 8.78% | 6.11% | 204.99% | 188.45% | -25.33% | 27.61% | - |
| Book Value per Share | 38.74 | 36.64 | 32.98 | 29.01 | 31.03 | 26.84 | 22.90 | 21.05 | 22.02 | 15.41 | 14.01 | 11.92 | 10.76 | 9.29 | 7.94 | 7.19 | 6.57 | 5.90 | 9.57 | 8.90 | 8.19 | 14.01 | 4.76 | 0.88 | 2.13 | 1.73 |
| Total Shareholders' Equity | 1.89B | 1.83B | 1.66B | 1.45B | 1.58B | 1.36B | 1.17B | 1.1B | 1.18B | 822.55M | 744.34M | 627.62M | 563.36M | 477.94M | 402.73M | 361.83M | 329.06M | 294.38M | 479.07M | 445.33M | 409.41M | 385.85M | 126.51M | 43.86M | 58.74M | 46.03M |
| Common Stock | 562K | 560K | 555K | 548K | 544K | 540K | 538K | 536K | 534K | 533K | 530K | 525K | 520K | 513K | 505K | 503K | 502K | 501K | 501K | 501K | 501K | 500K | 0 | 0 | 0 | 0 |
| Retained Earnings | 1.75B | 1.56B | 1.34B | 1.13B | 1.21B | 1.01B | 844.1M | 701.82M | 736.28M | 396.71M | 327.31M | 227.41M | 149.15M | 76.25M | 10.74M | -26.19M | -55.41M | -87.52M | 99.25M | 65.33M | 29.26M | 6.78M | 1.79M | 0 | 0 | 0 |
| Treasury Stock | -439.3M | -277.21M | -219.62M | -189.11M | -133.65M | -130.73M | -117.62M | -59.93M | -7.67M | -6.59M | -5.16M | -3.48M | -1.43M | -687K | -687K | -416K | -63K | -63K | -47K | -40K | -30K | -4K | 0 | 0 | 0 | 0 |
| Accumulated OCI | -28.37M | -37.66M | -34.49M | -31.56M | -19.03M | -19.8M | -44.16M | -25.75M | -19.32M | -26.35M | -23.52M | -23.41M | 739K | -104K | -13K | -2.77M | -2.45M | -1.33M | -999K | 313K | 1.11M | 320K | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill impairment and leverage
According to reported balance sheet data, PBH has successfully reduced its total debt from $1.2 billion in 2024Q3 to $1.0 billion by 2026Q4, signaling a strategic shift toward balance sheet consolidation as the company navigates a period of persistent organic revenue contraction and limited asset expansion.
The reduction in debt levels alongside a stable equity base suggests management is prioritizing financial flexibility over aggressive acquisition-led growth. This trajectory implies a defensive posture, likely intended to preserve credit quality while the core business faces headwinds in maintaining its historical market share.
Based on the latest quarterly filings, the company's debt-to-equity ratio has improved from 0.76 in 2024Q3 to 0.55 in 2026Q4, reflecting a disciplined approach to capital structure management that appears designed to mitigate interest rate sensitivity in a challenging consumer healthcare environment.
The consistent paydown of debt obligations suggests that the company is utilizing its free cash flow to deleverage rather than pursuing further debt-funded M&A. Investors should monitor whether this trend continues, as it may indicate a lack of attractive acquisition targets or a pivot toward organic growth initiatives.
As reported in financial statements, goodwill accounts for a significant portion of the $3.5 billion total asset base, with the figure rising from $527.9 million in 2024Q3 to $581.1 million in 2026Q4, highlighting a heavy reliance on acquired brand equity to support the company's valuation.
The high concentration of intangible assets warrants close scrutiny, as any sustained decline in the performance of core brands could necessitate non-cash impairment charges. While the asset-light model is efficient, the reliance on these book values may mask underlying volatility in the actual market value of the portfolio.
Based on the provided financial data, the company maintains a strong liquidity profile with a current ratio of 3.57 as of 2026Q4, providing a substantial buffer against short-term operational shocks despite the recent fluctuations in cash balances observed over the last ten quarters.
The elevated current ratio suggests that the company is well-positioned to meet its short-term obligations without needing to access external financing. This liquidity cushion appears sufficient to support ongoing marketing and promotional activities, which are critical for defending shelf space in a competitive retail landscape.
According to recent SEC filings, the company's equity base has expanded from $1.6 billion in 2024Q3 to $1.9 billion in 2026Q4, primarily driven by the consistent accumulation of retained earnings, which underscores the firm's ability to generate internal capital despite the current top-line growth challenges.
The steady growth in retained earnings reflects a disciplined reinvestment strategy that has successfully bolstered the company's net worth over time. This trend suggests that the business remains fundamentally profitable, even if the pace of revenue expansion has decelerated in recent reporting periods.
Quick answers to the most common questions about buying PBH stock.
As of 2026, Prestige Consumer Healthcare Inc. (PBH) had total assets of $3.55B including $431.5M in current assets.
Prestige Consumer Healthcare Inc. (PBH) carries total debt of $1.05B, offset by $63.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Prestige Consumer Healthcare Inc. (PBH) has total shareholders' equity (book value) of $1.89B ($38.74 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Prestige Consumer Healthcare Inc. (PBH) reported a current ratio of 3.57x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.